John-Arne Røttingen
Chief Executive Officer at The Wellcome Trust Ltd. (Investment Management)
Profile
Dr. John-Arne Røttingen is a Chief Executive Officer at The Wellcome Trust Ltd.
and a Chief Executive Officer at The Wellcome Trust Ltd.
He is on the Board of Directors at Program for Appropriate Technology in Health.
He began his career in basic discovery research, focusing on cellular calcium signalling, and trained as a medical doctor before transitioning to infectious disease epidemiology and global health.
He received his graduate degree from Harvard University, a graduate degree from the University of Oxford and a doctorate degree from the University of Oslo.
John-Arne Røttingen active positions
| Companies | Position | Start |
|---|---|---|
Program for Appropriate Technology in Health
 Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA. | Director/Board Member | - |
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Chief Executive Officer | 19/10/2023 |
The Wellcome Trust Ltd. (Investment Management)
 The Wellcome Trust Ltd. (Investment Management) Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. (Investment Management) (Wellcome-IM) is the investment management division of The Wellcome Trust Ltd., a politically and financially independent global charitable foundation headquartered in London, UK. The Wellcome Trust was founded in 1936, in accordance with Henry Wellcome’s will, to improve health by supporting scientific research and the study of medicine. Funding for this mission came from the profits of the pharmaceutical business he had built up over 50 years. Wellcome-IM manages The Wellcome Trust. | Chief Executive Officer | 01/01/2024 |
Training of John-Arne Røttingen
| University of Oslo | Doctorate Degree |
| University of Oxford | Graduate Degree |
| Harvard University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Program for Appropriate Technology in Health
Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA. | Commercial Services |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Miscellaneous |
The Wellcome Trust Ltd. (Investment Management)
The Wellcome Trust Ltd. (Investment Management) Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. (Investment Management) (Wellcome-IM) is the investment management division of The Wellcome Trust Ltd., a politically and financially independent global charitable foundation headquartered in London, UK. The Wellcome Trust was founded in 1936, in accordance with Henry Wellcome’s will, to improve health by supporting scientific research and the study of medicine. Funding for this mission came from the profits of the pharmaceutical business he had built up over 50 years. Wellcome-IM manages The Wellcome Trust. | Miscellaneous |
- Stock Market
- Insiders
- John-Arne Røttingen
